Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05332613 · ClinicalTrials.gov registry record · NA

Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease

A NA study of Non-alcoholic Fatty Liver Disease, sponsored by Weill Medical College of Cornell University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT05332613 is a NA study of Non-alcoholic Fatty Liver Disease that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 40 participants, below the 189-participant average among 50 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05332613, a NA study of Non-alcoholic Fatty Liver Disease, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

This study will assess the impact of time-restricted eating (8 hours of eating each day) with standard of care lifestyle recommendations (hypocaloric, Mediterranean diet and 30 minutes of exercise on at least 5 days/week) on the degree of fat in the liver as measured by magnetic resonance imaging.

Interventions

  • BEHAVIORAL SOC
  • BEHAVIORAL TRE plus SOC
  • BEHAVIORAL TRE

Study Locations (1)

New York

  • Weill Cornell Medicine - New York

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2022-04-27
Est. Completion 2030-12-31
Phase NA

What the Registry Record Tells You About NCT05332613

The ClinicalTrials.gov registry entry for NCT05332613 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 189-participant average among 50 other Non-alcoholic Fatty Liver Disease trials with a reported enrollment target (79% lower). The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Non-alcoholic Fatty Liver Disease appearing as the primary indexed condition, and to 3 interventions - of which SOC is the first listed.

NCT05332613 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05332613 about?

NCT05332613 is a clinical study titled "Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver Disease". This study will assess the impact of time-restricted eating (8 hours of eating each day) with standard of care lifestyle recommendations (hypocaloric, Mediterranean diet and 30 minutes of exercise on at least 5 days/week) on the degree of fat in the liver as measured by magnetic resonance imaging.

What is the current status of trial NCT05332613?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2022-04-27. Estimated completion is 2030-12-31.

What conditions does trial NCT05332613 study?

This clinical trial studies the following conditions: Non-alcoholic Fatty Liver Disease.

What interventions are being tested in trial NCT05332613?

The interventions under investigation include: SOC (BEHAVIORAL), TRE plus SOC (BEHAVIORAL), TRE (BEHAVIORAL).

Who is sponsoring clinical trial NCT05332613?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05332613 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Non-alcoholic Fatty Liver Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.